Assessment of Adherence and Asthma Medication Ratio for a Once-Daily and Twice-Daily Inhaled Corticosteroid/Long-Acting β-Agonist for Asthma
- 1 May 2019
- journal article
- research article
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 7 (5) , 1488-1496.e7
Abstract
No abstract availableKeywords
Funding Information
- GlaxoSmithKline
- GlaxoSmithKline
This publication has 22 references indexed in Scilit:
- Clinical Burden and Predictors of Asthma Exacerbations in Patients on Guideline-based Steps 4-6 Asthma Therapy in the TENOR CohortThe Journal of Allergy and Clinical Immunology: In Practice, 2014
- Asthma control, cost and race: results from a national surveyJournal of Asthma, 2013
- Short-acting β-agonist use and its ability to predict future asthma-related outcomesAnnals of Allergy, Asthma & Immunology, 2012
- Effect of asthma exacerbations on health care costs among asthmatic patients with moderate and severe persistent asthmaJournal of Allergy and Clinical Immunology, 2012
- Uncontrolled persistent allergic asthma in practice: eXpeRience registry baseline characteristicsCurrent Medical Research and Opinion, 2011
- The burden of adult asthma in the United States: Evidence from the Medical Expenditure Panel SurveyJournal of Allergy and Clinical Immunology, 2011
- Costs of asthma in the United States: 2002-2007Journal of Allergy and Clinical Immunology, 2011
- The status of asthma control in the U.S. adult populationAllergy and Asthma Proceedings, 2009
- Association between adherence with fixed dose combination fluticasone propionate/salmeterol on asthma outcomes and costsCurrent Medical Research and Opinion, 2008
- Asthma Quality-of-Care Markers Using Administrative DataChest, 2005